Range Cancer Therapeutics ETF (CNCR)
NASDAQ: CNCR · Real-Time Price · USD
11.73
+0.31 (2.76%)
Jan 15, 2025, 9:30 AM EST - Market open
CNCR Holdings List
As of Jan 10, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | RXRX | Recursion Pharmaceuticals, Inc. | 3.50% |
2 | DNA | Ginkgo Bioworks Holdings, Inc. | 2.64% |
3 | VOR | Vor Biopharma Inc. | 2.59% |
4 | EXEL | Exelixis, Inc. | 2.20% |
5 | SWTX | SpringWorks Therapeutics, Inc. | 2.03% |
6 | PGEN | Precigen, Inc. | 1.97% |
7 | BMY | Bristol-Myers Squibb Company | 1.88% |
8 | REPL | Replimune Group, Inc. | 1.78% |
9 | ZYME | Zymeworks Inc. | 1.77% |
10 | CMPX | Compass Therapeutics, Inc. | 1.74% |
11 | GNLX | Genelux Corporation | 1.71% |
12 | GLUE | Monte Rosa Therapeutics, Inc. | 1.70% |
13 | BPMC | Blueprint Medicines Corporation | 1.70% |
14 | BNTX | BioNTech SE | 1.67% |
15 | XNCR | Xencor, Inc. | 1.64% |
16 | ELVN | Enliven Therapeutics, Inc. | 1.63% |
17 | SDGR | Schrödinger, Inc. | 1.63% |
18 | KPTI | Karyopharm Therapeutics Inc. | 1.58% |
19 | RVMD | Revolution Medicines, Inc. | 1.58% |
20 | JANX | Janux Therapeutics, Inc. | 1.57% |
21 | MGNX | MacroGenics, Inc. | 1.56% |
22 | IMCR | Immunocore Holdings plc | 1.55% |
23 | HCM | HUTCHMED (China) Limited | 1.53% |
24 | NUVB | Nuvation Bio Inc. | 1.52% |
25 | ACLX | Arcellx, Inc. | 1.51% |
26 | MRUS | Merus N.V. | 1.47% |
27 | DAWN | Day One Biopharmaceuticals, Inc. | 1.45% |
28 | MRK | Merck & Co., Inc. | 1.41% |
29 | RCUS | Arcus Biosciences, Inc. | 1.41% |
30 | ERAS | Erasca, Inc. | 1.41% |
31 | GMAB | Genmab A/S | 1.40% |
32 | IPHA | Innate Pharma S.A. | 1.39% |
33 | INBX | Inhibrx Biosciences, Inc. | 1.37% |
34 | APLM | Apollomics, Inc. | 1.36% |
35 | CRBU | Caribou Biosciences, Inc. | 1.36% |
36 | KYMR | Kymera Therapeutics, Inc. | 1.32% |
37 | AURA | Aura Biosciences, Inc. | 1.28% |
38 | TYRA | Tyra Biosciences, Inc. | 1.27% |
39 | ZNTL | Zentalis Pharmaceuticals, Inc. | 1.25% |
40 | ALLO | Allogene Therapeutics, Inc. | 1.25% |
41 | ARVN | Arvinas, Inc. | 1.24% |
42 | GERN | Geron Corporation | 1.22% |
43 | IMRX | Immuneering Corporation | 1.21% |
44 | SNDX | Syndax Pharmaceuticals, Inc. | 1.21% |
45 | NRIX | Nurix Therapeutics, Inc. | 1.20% |
46 | RAPT | RAPT Therapeutics, Inc. | 1.18% |
47 | IBRX | ImmunityBio, Inc. | 1.16% |
48 | NUVL | Nuvalent, Inc. | 1.15% |
49 | ACRV | Acrivon Therapeutics, Inc. | 1.12% |
50 | CGEM | Cullinan Therapeutics, Inc. | 1.11% |
As of Jan 10, 2025